FG
PRVA icon

Formula Growth’s Privia Health PRVA Stock Holding History

Formula Growth’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-91,537
Closed -$2.11M – 136
2023
Q4 		$2.11M Sell
91,537
-34,400
-27% -$770K 0.68% 67
2023
Q3 		$2.9M Buy
125,937
+10,207
+9% +$260K 0.99% 36
2023
Q2 		$3.02M Buy
+115,730
New +$3.06M 0.96% 35

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Formula Growth's PRVA Position: Q1 2024 in Review

Formula Growth sold out of Privia Health (PRVA) in Q1 2024, closing a stake of 91,537 shares — an estimated $2.11M sold.

Formula Growth first reported a position in PRVA in Q2 2023 and held it in 3 quarters. The position peaked at $3.02M in Q2 2023. 234 funds tracked by Wall St. Rank hold PRVA as of Q1 2024.

  • Formula Growth reported no remaining Privia Health position as of Q1 2024 after selling out during the quarter.
  • Formula Growth sold 91,537 Privia Health shares in Q1 2024, an estimated $2.11M.
  • Formula Growth first reported a position in Privia Health in Q2 2023 and held it in 3 quarters.
  • Formula Growth's Privia Health position peaked at $3.02M in Q2 2023.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q1 2024.

Based on Formula Growth's 13F filing for Q1 2024, filed 14 May 2024.